Androgenicity in the rat fetus of metabolites of testosterone and antagonism by cyproterone acetate.
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000311:Adrenal Glands / Q000187:drug effects; D000704:Analysis of Variance; D000726:Androgen Antagonists; D000731:Androstanes; D000738:Androsterone; D000818:Animals; D000886:Anthropometry; D001835:Body Weight; D013196:Dihydrotestosterone; D004336:Drug Antagonism; D005260:Female; D005315:Fetal Diseases / Q000139:chemically induced*; D005333:Fetus / Q000187:drug effects*; D007021:Hypospadias / Q000139:chemically induced; D008297:Male; D009929:Organ Size; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced; D011278:Pregnanes / Q000494:pharmacology; D051381:Rats; D013261:Sterols; D013739:Testosterone; D014521:Urethra / Q000187:drug effects; D014770:Virilism / Q000139:chemically induced*
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000726:Androgen Antagonists; D000731:Androstanes; D011278:Pregnanes; D013261:Sterols; D013196:Dihydrotestosterone; D013739:Testosterone; D000738:Androsterone